EditorialKommentar
Heterogeneity of Treatment Effect — An Evolution in Subgroup Analysis
NEJM Evidence · 26.03.2024 · 3 (4)
DOI: 10.1056/evide2400054 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM Evidence, erschienen am 26.03.2024. Verfasst von Christopher J Yarnell und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Scarborough Health Network, Toronto. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Research DesignHumansTreatment OutcomeData Interpretation, Statistical
Autor:innen und Institutionen
- Department of Critical Care Medicine, Scarborough Health Network, Toronto.
- Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto.
- Division of General Internal Medicine, Sinai Health System, Toronto.
Zitieren
APA
Yarnell, C. J., & Fralick, M. (2024). Heterogeneity of Treatment Effect — An Evolution in Subgroup Analysis. NEJM Evidence, 3(4). https://doi.org/10.1056/evide2400054
Vancouver
Yarnell CJ, Fralick M. Heterogeneity of Treatment Effect — An Evolution in Subgroup Analysis. NEJM Evidence. 2024;3(4). doi:10.1056/evide2400054
BibTeX
@article{Yarnell2024,
author = {Yarnell, Christopher J and Fralick, Michael},
title = {Heterogeneity of Treatment Effect — An Evolution in Subgroup Analysis},
journal = {NEJM Evidence},
year = {2024},
volume = {3},
number = {4},
doi = {10.1056/evide2400054}
}
EUVIMED